Secondary Logo

January 2, 2018 - Volume 32 - Issue 1
pp: 1-131

An advanced BLT-humanized mouse model for extended HIV-1 cure studies

Lavender, Kerry J.; Pace, Craig; Sutter, Kathrin; More

AIDS. 32(1):1-10, January 2, 2018.

CONCISE COMMUNICATION



Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

Siefried, Krista J.; Mao, Limin; Cysique, Lucette A.; More

AIDS. 32(1):35-48, January 2, 2018.

Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children

LaCourse, Sylvia M.; Pavlinac, Patricia B.; Cranmer, Lisa M.; More

AIDS. 32(1):69-78, January 2, 2018.

CONCISE COMMUNICATIONS


Abacavir use and risk of recurrent myocardial infarction

Sabin, Caroline A.; Ryom, Lene; d’Arminio Monforte, Antonella; More

AIDS. 32(1):79-88, January 2, 2018.


Costs and benefits of on-demand HIV preexposure prophylaxis in MSM

Durand-Zaleski, Isabelle; Mutuon, Pierre; Charreau, Isabelle; More

AIDS. 32(1):95-102, January 2, 2018.

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases

Engelhard, Esther A.N.; Smit, Colette; van Dijk, Peter R.; More

AIDS. 32(1):103-112, January 2, 2018.

Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes

Caniglia, Ellen C.; Zash, Rebecca; Jacobson, Denise L.; More

AIDS. 32(1):113-120, January 2, 2018.


Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors

Cid-Silva, Purificación; Margusino-Framiñán, Luis; Balboa-Barreiro, Vanesa; More

AIDS. 32(1):121-125, January 2, 2018.